Kedar Kirtane
- Oncology top 10%
- Immunology
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Public Health, Environmental and Occupational Health
- Co-authors
- Christine H. ChungStephanie J. LeeHany ElmariahDaniel Abate‐DagaJameel MuzaffarShahla BariGary H. LymanSarah Buckley
- Topics
- Cancer Immunotherapy and Biomarkers (19 papers)CAR-T cell therapy research (17 papers)Head and Neck Cancer Studies (17 papers)
- Partner nations
- United StatesTaiwanNew Zealand
In The Last Decade
Kedar Kirtane
53 papers receiving 739 citations
Peers
Comparison fields: 5 of 87
- Oncology 410
- Immunology 176
- Molecular Biology 133
- Pulmonary and Respiratory Medicine 118
- Public Health, Environmental and Occupational Health 105
Countries citing papers authored by Kedar Kirtane
This map shows the geographic impact of Kedar Kirtane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kedar Kirtane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kedar Kirtane more than expected).
Fields of papers citing papers by Kedar Kirtane
This network shows the impact of papers produced by Kedar Kirtane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kedar Kirtane. The network helps show where Kedar Kirtane may publish in the future.
Co-authorship network of co-authors of Kedar Kirtane
This figure shows the co-authorship network connecting the top 25 collaborators of Kedar Kirtane. A scholar is included among the top collaborators of Kedar Kirtane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kedar Kirtane. Kedar Kirtane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 2 | |
| 12 | 6 | |
| 13 | 7 | |
| 14 | 8 | |
| 15 | 21 | |
| 16 | 49 | |
| 17 | 3 | |
| 18 | 11 | |
| 19 | 16 | |
| 20 | 26 |
About Kedar Kirtane
Kedar Kirtane is a scholar working on Otorhinolaryngology, Oncology and Immunology, having authored 61 papers that have together received 743 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), CAR-T cell therapy research (17 papers) and Head and Neck Cancer Studies (17 papers). The work is most often cited by research in Otorhinolaryngology (95 citations), Oncology (410 citations) and Transplantation (38 citations). Kedar Kirtane has collaborated with scholars based in United States, Taiwan and New Zealand. Frequent co-authors include Christine H. Chung, Stephanie J. Lee, Hany Elmariah, Daniel Abate‐Daga, Jameel Muzaffar, Shahla Bari, Gary H. Lyman, Sarah Buckley, Laura B. Oswald and Roland B. Walter. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.